Literature DB >> 10971616

beta-amyloid neurotoxicity is mediated by a glutamate-triggered excitotoxic cascade in rat nucleus basalis.

T Harkany1, I Abrahám, W Timmerman, G Laskay, B Tóth, M Sasvári, C Kónya, J B Sebens, J Korf, C Nyakas, M Zarándi, K Soós, B Penke, P G Luiten.   

Abstract

Whereas a cardinal role for beta-amyloid protein (Abeta) has been postulated as a major trigger of neuronal injury in Alzheimer's disease, the pathogenic mechanism by which Abeta deranges nerve cells remains largely elusive. Here we report correlative in vitro and in vivo evidence that an excitotoxic cascade mediates Abeta neurotoxicity in the rat magnocellular nucleus basalis (MBN). In vitro application of Abeta to astrocytes elicits rapid depolarization of astroglial membranes with a concomitant inhibition of glutamate uptake. In vivo Abeta infusion by way of microdialysis in the MBN revealed peak extracellular concentrations of excitatory amino acid neurotransmitters within 20-30 min. Abeta-triggered extracellular elevation of excitatory amino acids coincided with a significantly enhanced intracellular accumulation of Ca2+ in the Abeta injection area, as was demonstrated by 45Ca2+ autoradiography. In consequence of these acute processes delayed cell death in the MBN and persistent loss of cholinergic fibre projections to the neocortex appear as early as 3 days following the Abeta-induced toxic insult. Such a sequence of Abeta toxicity was effectively antagonized by the N-methyl-D-aspartate (NMDA) receptor ligand dizocilpine maleate (MK-801). Moreover, Abeta toxicity in the MBN decreases with advancing age that may be associated with the age-related loss of NMDA receptor expression in rats. In summary, the present results indicate that Abeta compromises neurons of the rat MBN via an excitotoxic pathway including astroglial depolarization, extracellular glutamate accumulation, NMDA receptor activation and an intracellular Ca2+ overload leading to cell death.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10971616     DOI: 10.1046/j.1460-9568.2000.00164.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  60 in total

1.  Emerging Therapeutic Strategies for Treating Alzheimer's Disease in Primary Care.

Authors: 
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2003-12

2.  Inhibition of calpain prevents NMDA-induced cell death and beta-amyloid-induced synaptic dysfunction in hippocampal slice cultures.

Authors:  V Nimmrich; K G Reymann; M Strassburger; U H Schöder; G Gross; A Hahn; H Schoemaker; K Wicke; A Möller
Journal:  Br J Pharmacol       Date:  2010-03-03       Impact factor: 8.739

Review 3.  Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connections.

Authors:  Wojciech Danysz; Chris G Parsons
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

4.  Endogenous overproduction of beta-amyloid induces tau hyperphosphorylation and decreases the solubility of tau in N2a cells.

Authors:  Y-P Wang; X-C Wang; Q Tian; Y Yang; Q Zhang; J-Y Zhang; Y-C Zhang; Z-F Wang; Q Wang; H Li; J-Z Wang
Journal:  J Neural Transm (Vienna)       Date:  2006-06-06       Impact factor: 3.575

Review 5.  Alzheimer's disease amyloid beta-protein and synaptic function.

Authors:  Tomas Ondrejcak; Igor Klyubin; Neng-Wei Hu; Andrew E Barry; William K Cullen; Michael J Rowan
Journal:  Neuromolecular Med       Date:  2009-09-16       Impact factor: 3.843

Review 6.  Animal models in the drug discovery pipeline for Alzheimer's disease.

Authors:  Debby Van Dam; Peter Paul De Deyn
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

7.  A β-amyloid oligomer directly modulates P/Q-type calcium currents in Xenopus oocytes.

Authors:  M Mezler; S Barghorn; H Schoemaker; G Gross; V Nimmrich
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

8.  Influence of hippocampal GABAB receptor inhibition on memory in rats with acute β-amyloid toxicity.

Authors:  Azam Almasi; Mohammad Zarei; Safoura Raoufi; Abdolrahman Sarihi; Iraj Salehi; Alireza Komaki; Nasrin Hashemi-Firouzi; Siamak Shahidi
Journal:  Metab Brain Dis       Date:  2018-07-23       Impact factor: 3.584

9.  High performance liquid chromatography determination of L-glutamate, L-glutamine and glycine content in brain, cerebrospinal fluid and blood serum of patients affected by Alzheimer's disease.

Authors:  Tommaso Nuzzo; Andrea Mancini; Mattia Miroballo; Alessia Casamassa; Anna Di Maio; Giorgia Donati; Giulia Sansone; Lorenzo Gaetani; Federico Paolini Paoletti; Andrea Isidori; Paolo Calabresi; Francesco Errico; Lucilla Parnetti; Alessandro Usiello
Journal:  Amino Acids       Date:  2021-02-22       Impact factor: 3.520

10.  Alterations of Ca²⁺-responsive proteins within cholinergic neurons in aging and Alzheimer's disease.

Authors:  David Riascos; Alexander Nicholas; Ravand Samaeekia; Rustam Yukhananov; M-Marsel Mesulam; Eileen H Bigio; Sandra Weintraub; Ling Guo; Changiz Geula
Journal:  Neurobiol Aging       Date:  2013-12-25       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.